TORONTO (May 14, 2019) – According to a new study published today in
The Journal of the American Medical Association (JAMA), patients who have severe obstructive sleep apnea have a significantly higher risk of complications related to their heart in the first 30 days after major surgery.
"We found that the risk of postoperative complications related to their heart was 50 per cent higher in patients with sleep apnea compared to those without sleep apnea," says Dr. Frances Chung, a Clinician Investigator with the Krembil Research Institute and a Professor in the Department of Anesthesiology and Pain Management at the University Health Network and University of Toronto.
Severe obstructive sleep apnea is the most common type of sleep breathing disorder and has also been associated with a higher risk of cardiac diseases, hypertension, stroke, atrial fibrillation, diabetes and cognitive impairment. It is also associated with three-fold increase in death rate.
During obstructive sleep apnea, the upper airway is blocked by the tongue and surrounding tissues during sleep, which may result in a lack of oxygen to the brain. "As a result, in the general population, obstructive sleep apnea is associated with a higher risk of cardiovascular complications including high blood pressure, angina, irregular heartbeat, heart failure and sudden death," says Dr. Chung. "In this study, we wanted to determine whether sleep apnea would pose a similar risk to surgical patients."
Some 30 per cent of our surgical population has unrecognized moderate to severe sleep apnea. The patients in this study were not diagnosed and they were not treated before surgery. "The key takeaway here is that if patients have symptoms of sleep apnea, perhaps they should be treated before undergoing major surgery," says Dr. Chung. "Further study is needed to determine how best to prevent patients with severe sleep apnea from having a higher risk of heart complications."
About the Krembil Research Institute The Krembil Research Institute (or "Krembil") is one of the principal research institutes of the University Health Network. The Krembil is focused on research programs dedicated to brain & spine, arthritis and vision disorders, with a goal to alleviate debilitating chronic disease through basic, translational & clinical research. Krembil is located at the Toronto Western Hospital in downtown Toronto and is supported by the Toronto General & Western Hospital Foundation, which raises funds for research, education and patient care.
About University Health Network University Health Network (UHN) comprises Toronto General and Toronto Western Hospitals, the Princess Margaret Cancer Centre and The Michener Institute of Education. The scope of research and complexity of cases at UHN has made it a national & international source for discovery, education, commercialization and patient care. UHN has the largest hospital-based research program in Canada, spanning cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. UHN is affiliated with the University of Toronto.
MEDIA CONTACT Heather Sherman, Senior Advisor, Public Affairs Neuroscience | Arthritis | Vision University Health Network
Phone: 416 603 5294